Vaneck Vectors Global Health Leaders ETF (ASX:HLTH)

ASX:HLTH Holdings Information

ASX:HLTH is an equity ETF with a total of 10 individual holdings. The top holdings are Illumina stock at 3.81%, Halozyme Therapeutics at 3.34%, West Pharmaceutical Services at 2.91%, Exelixis at 2.67%, and argenx SE at 2.67%.

• Total Holdings: 10
• Top 10 Percentage: 27.90%
• Asset Class: Equity
• ETF Category: Health Care
• Assets: 57.80M
• PE Ratio: 20.34

Top 25 Holdings

As of Sep 18, 2026

Filter results

No.	Symbol	Name	% Weight	Shares
1	ILMN	Illumina, Inc.	3.81%	6,581
2	HALO	Halozyme Therapeutics, Inc.	3.34%	12,297
3	WST	West Pharmaceutical Services, Inc.	2.91%	3,325
4	EXEL	Exelixis, Inc.	2.67%	18,982
5	ARGX	argenx SE	2.67%	1,118
6	DXCM	DexCom, Inc.	2.63%	12,186
7	n/a	Cash	2.62%	n/a
8	INCY	Incyte Corporation	2.56%	8,459
9	MRK	Merck & Co., Inc.	2.40%	6,771
10	EHC	Encompass Health Corporation	2.29%	7,799

Data Source: Finnhub Last updated: Sep 18, 2026

ETF holdings data is provided by Finnhub. Holdings are typically published by the ETF issuer at the end of each trading day.

Update frequency:

Daily

Last checked:

Sep 22, 2026

Data Sources Report a data error